You have 9 free searches left this month | for more free features.

Breast - Male

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Male Breast Cancer Patients at Methodist Health System

Recruiting
  • Male Breast Cancer Patients
  • managing Male Breast Cancer Patients at Methodist Health System
  • Dallas, Texas
  • +1 more
Nov 13, 2023

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Breast - Female, Male Breast Cancer Trial in Charlotte (Pembrolizumab, Paclitaxel)

Completed
  • Breast - Female
  • Male Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 25, 2023

Male Breast Cancer Trial in Groningen (AndroGel)

Not yet recruiting
  • Male Breast Cancer
  • Groningen, Netherlands
    UMCG
May 17, 2022

Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)

Recruiting
  • Breast Cancer
  • +7 more
  • Dendritic Cell Vaccine (DC1)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 23, 2022

Finasteride and Male Breast Cancer - A Register-Based Nested

Completed
  • Male Breast Cancer
    • (no location specified)
    Feb 7, 2022

    Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

    Completed
    • Male Breast Cancer
    • +7 more
    • propranolol hydrochloride
    • Correlative Studies
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 4, 2022

    Molecular and Cellular Analysis of Breast Cancer

    Suspended
    • Breast - Female
    • Breast - Male
      • Stanford, California
        Stanford University Cancer Institute
      Feb 11, 2022

      Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)

      Recruiting
      • Breast Cancer Female
      • +7 more
      • DC1 Vaccine
      • WOKVAC Vaccine
      • Tampa, Florida
      • +6 more
      Apr 4, 2022

      Breast Cancer, Nonsmall Cell Lung Cancer Trial in Beijing ([14C]GB491)

      Completed
      • Breast Cancer
      • Nonsmall Cell Lung Cancer
      • Beijing, Beijing, China
        Beijing GoBroad Boren Hospital
      May 5, 2023

      Treating Patients With Stage IV Breast Cancer

      Active, not recruiting
      • Central Nervous System Metastases
      • +15 more
      • hyperfractionated radiation therapy
      • +2 more
      • North Chicago, Illinois
        University of Chicago
      Dec 6, 2021

      Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)

      Completed
      • Metastatic Breast Cancer
      • Metastatic Gastric Cancer
      • Changchun, Jilin, China
        Affiliated Hospital of Changchun University of Traditional Chine
      Mar 1, 2023

      Breastfeeding, Breast Fed, Breast Feeding, Exclusive Trial in Hawassa (Breastfeeding Education and Support)

      Recruiting
      • Breastfeeding
      • +4 more
      • Breastfeeding Education and Support
      • Hawassa, Southern Nations, Nationalities, And Peoples' Region, Ethiopia
        Hadiya Zone
      May 15, 2022

      Breast Cancer Trial in Berlin (420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection, Perjeta (EU origin) 420 mg in 14 mL

      Recruiting
      • Breast Cancer
      • 420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection
      • +2 more
      • Berlin, Germany
        CRS Clinical Research Services Berlin GmbH
      Jul 20, 2022

      Progress of Breast Cancer Cases in Males and Assessment of

      Recruiting
      • Breast Cancer, Male
        • Ferrol, A Coruña, Spain
        • +53 more
        Jul 19, 2022

        Prostate Cancer Trial in Chisinau (enzalutamide, enzalutamide Placebo, digoxin)

        Completed
        • Prostate Cancer
        • Chisinau, Moldova, Republic of
          Site MD37301
        Jan 14, 2022

        Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

        Completed
        • Breast Cancer
        • +2 more
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Jan 13, 2022

        Breast Cancer, Breast Cancer, Female, Breast Cancer, Male Trial in Tampa (Fluoro-D-glucose-positron Emission Tomography,

        Withdrawn
        • Breast Cancer
        • +3 more
        • Fluoro-D-glucose-positron Emission Tomography
        • +2 more
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Dec 3, 2020

        HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast

        Active, not recruiting
        • HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
        • Birmingham, Alabama
        • +54 more
        Nov 21, 2022

        Malignant Tumor of Breast, Malignant Tumors of Digestive Organs, Malignant Tumors of Female Genital Organs Trial in Houston

        Recruiting
        • Malignant Neoplasm of Breast
        • +4 more
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Dec 29, 2021

        Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

        Active, not recruiting
        • Advanced Malignant Neoplasm
        • +38 more
        • Bevacizumab
        • +5 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 18, 2022

        Breast Cancer Trial in Worldwide

        Active, not recruiting
        • Breast Cancer
          • Birmingham, Alabama
          • +92 more
          Jul 27, 2021

          Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

          Completed
          • Adult Solid Tumor
          • +38 more
          • Philadelphia, Pennsylvania
            Abramson Cancer Center of The University of Pennsylvania
          Feb 18, 2021

          HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,

          Completed
          • HER2-positive Breast Cancer
          • +7 more
          • HER-2/neu peptide vaccine
          • +2 more
          • Seattle, Washington
            Fred Hutchinson Cancer Research Center/University of Washington
          Feb 4, 2020